A. O'Connor

发表

High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.

H. Roche, J. Gibney, G. Boran, 2010, The Journal of clinical endocrinology and metabolism.

Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.

H. Roche, J. Gibney, G. Boran, 2010, The Journal of clinical endocrinology and metabolism.

Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome : results from a cross-sectional analysis and a randomized , placebo-controlled , crossover trial 1 – 4

H. Roche, J. Gibney, G. Boran, 2011 .

Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.

H. Roche, J. Gibney, G. Boran, 2011, The American journal of clinical nutrition.

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome

H. Roche, J. Gibney, G. Boran, 2016, International journal of endocrinology.

Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet

H. Roche, J. Gibney, A. O'Connor, 2010, Proceedings of the Nutrition Society.

Women with polycystic ovary syndrome (PCOS) have equivalent lipid profiles but a lower high-molecular-weight (HMW) adiponectin levels compared with controls matched for age, BMI and insulin resistance

H. Roche, J. Gibney, A. O'Connor, 2008, Proceedings of the Nutrition Society.

Polycystic ovary syndrome inﬂuences the level of serum amyloid A and activity of phospholipid transfer protein in HDL 2 and HDL 3

I. Young, J. Gibney, J. McEneny, 2014 .

Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL2 and HDL3

I. Young, J. Gibney, J. McEneny, 2014 .

Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance

J. Gibney, G. Boran, T. Kyaw Tun, 2013, Clinical endocrinology.

Metabolic and hormonal aspects of polycystic ovary syndrome: the impact of diet

H. Roche, J. Gibney, A. O'Connor, 2010, Proceedings of the Nutrition Society.

High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.

A. O'Connor, N. Phelan, T. K. Tun, 2010, The Journal of clinical endocrinology and metabolism.